- Home
- EVI vs NGEN Comparison
EVI vs NGEN Comparison
Compare EVI & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVI | NGEN |
|---|---|---|
| Founded | 1959 | 2017 |
| Country | United States | Canada |
| Employees | N/A | 9 |
| Industry | Other Consumer Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.6M | 197.5M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | EVI | NGEN |
|---|---|---|
| Price | $15.42 | $1.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $35.00 | $18.00 |
| AVG Volume (30 Days) | 83.9K | ★ 825.2K |
| Earning Date | 05-15-2026 | 04-02-2026 |
| Dividend Yield | ★ 1.81% | N/A |
| EPS Growth | ★ 32.43 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $389,830,000.00 | N/A |
| Revenue This Year | $15.53 | N/A |
| Revenue Next Year | $3.83 | N/A |
| P/E Ratio | $49.55 | ★ N/A |
| Revenue Growth | ★ 10.26 | N/A |
| 52 Week Low | $14.06 | $1.70 |
| 52 Week High | $34.82 | $5.93 |
Technical Indicators
Market Signals| Indicator | EVI | NGEN |
|---|---|---|
| Relative Strength Index (RSI) | 42.43 | 36.74 |
| Support Level | $14.06 | $1.85 |
| Resistance Level | $21.36 | $2.35 |
| Average True Range (ATR) | 0.92 | 0.15 |
| MACD | 0.13 | 0.04 |
| Stochastic Oscillator | 40.12 | 3.96 |
Price Performance
Historical ComparisonAbout EVI EVI Industries Inc.
EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.
About NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.